Next Article in Journal
Beneficial Effects of Ethanolic and Hexanic Rice Bran Extract on Mitochondrial Function in PC12 Cells and the Search for Bioactive Components
Previous Article in Journal
Identification of Cultured and Natural Astragalus Root Based on Monosaccharide Mapping
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 20
Issue 9
10.3390/molecules200916491
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Spectroscopic Study on the Interaction between Naphthalimide-Polyamine Conjugates and Bovine Serum Albumin (BSA)

by
Zhi-Yong Tian
1,†,
Li-Na Song
1,†,
Yuan Zhao
2,†,
Feng-Lei Zang
1,
Zhong-Hua Zhao
1,
Nan-Hao Chen
3,
Xue-Jun Xu
2,4,* and
Chao-Jie Wang
2,*
1
Institute of Chemical Biology, Henan University, Kaifeng 475004, China
2
The Key Laboratory of Natural Medicine and Immuno-Engineering, Henan University, Kaifeng 475004, China
3
School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China
4
Huaihe Clinical Institute, Henan University, Kaifeng 475004, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Molecules 2015, 20(9), 16491-16523; https://doi.org/10.3390/molecules200916491
Submission received: 13 July 2015 / Revised: 14 August 2015 / Accepted: 14 August 2015 / Published: 11 September 2015
(This article belongs to the Section Molecular Diversity)
Browse Figures
Versions Notes

Abstract

:
The effect of a naphthalimide pharmacophore coupled with diverse substituents on the interaction between naphthalimide-polyamine conjugates 1–4 and bovine serum albumin (BSA) was studied by UV absorption, fluorescence and circular dichroism (CD) spectroscopy under physiological conditions (pH = 7.4). The observed spectral quenching of BSA by the compounds indicated that they could bind to BSA. Furthermore, caloric fluorescent tests revealed that the quenching mechanisms of compounds 1–3 were basically static type, but that of compound 4 was closer to a classical type. The Ksv values at room temperature for compound-BSA complexes-1-BSA, 2-BSA, 3-BSA and 4-BSA were 1.438 × 104, 3.190 × 104, 5.700 × 104 and 4.745 × 105, respectively, compared with the value of MINS, 2.863 × 104 at Ex = 280 nm. The obtained quenching constant, binding constant and thermodynamic parameter suggested that the binding between compounds 1–4 with BSA protein, significantly affected by the substituted groups on the naphthalene backbone, was formed by hydrogen bonds, and other principle forces mainly consisting of charged and hydrophobic interactions. Based on results from the analysis of synchronous three-dimensional fluorescence and CD spectra, we can conclude that the interaction between compounds 1–4 and BSA protein has little impact on the BSA conformation. Calculated results obtained from in silico molecular simulation showed that compound 1 did not prefer either enzymatic drug sites I or II over the other. However, DSII in BSA was more beneficial than DSI for the binding between compounds 2–4 and BSA protein. The binding between compounds 1–3 and BSA was hydrophobic in nature, compared with the electrostatic interaction between compound 4 and BSA.

Graphical Abstract

1. Introduction

Proteins are important chemical substances in cellular life and a major target for many types of medicine; furthermore, changes of their contents in serum can display human health conditions [1,2]. Serum albumin (SA), including bovine serum albumin (BSA) and human serum albumin (HSA), is the main soluble protein constituent of the circulatory system. SA plays an important and efficient role in drug delivery because of its ability to reversibly bind to a large variety of exogenous compounds, including fatty acids, amino acids, drugs and pharmaceuticals [3,4,5]. Due to its medical importance, low cost, ready availability, unusual ligand-binding properties and similarity to human serum albumin (HSA) in terms of spatial structure and chemical composition [6,7,8], BSA was selected as the model protein for this research. It is well known that 1,8-naphthalimide derivatives can intercalate DNA base pairs and bind to SA [2,9,10]. Similarly, polyamines can also bind to SA [11,12,13,14]. Naphthalimide-polyamine conjugates have been proven to exhibit good activity in vitro [15,16,17,18], intercalate DNA base pairs, and cause conformational variations in DNA [19]. MINS, a mononaphthalimide-polyamine conjugate, can bind to BSA, but causes a weak conformational change in BSA [20]. In this study, the impact of naphthalimide coupled with diverse substituent groups on the interaction between naphthalimide-polyamine conjugates 1–4 (Figure 1) and BSA was examined through ultraviolet (UV), fluorescence (FL), and circular dichroism (CD) spectroscopy and molecular modeling methods. The binding constants and main types of binding force therein were also investigated.

2. Results and Discussion

2.1. UV Spectroscopic Characteristics

As shown in Figure 2, the UV spectra of BSA in the presence of different concentrations of compounds 1–4 were measured by an ultraviolet-visible range spectrophotometer. The free BSA had a peak at 278 nm (Figure 2), which was obviously increased with elevated concentrations of compounds 1, 3 and 4 (Figure 3). However, it could not be deduced directly that the BSA complexes with compounds 1, 3 and 4 were formed due to the overlapped absorptions of these compounds and BSA in the same region (Figure 2). Compound 2 had no peak at 278 nm. Although the addition of compound 2 to BSA led to a continuous increase to a lesser extent (Figure 3), the compound-BSA complex might have been formed because of the up-regulated absorption at 278 nm (Figure 3). At least, the spectral result of compound 2 indicated that it penetrated the hydrophobic sites of BSA sub-domain and bonded with the chromophores of tyrosine and tryptophan residues, and other unbonded residues were buried in a hydrophobic cave [21]. Interestingly, the gains in the absorption intensity of the postulated complexes of compounds 1, 3, 4 with BSA at 278 nm were less than expected (Figure 2). More evidence is needed to confirm the binding of these three compounds to BSA.
Molecules 20 16491 g001 550
Figure 1. Structures of naphthalimide-polyamine conjugates.
Figure 1. Structures of naphthalimide-polyamine conjugates.
Molecules 20 16491 g001
Molecules 20 16491 g002a 550Molecules 20 16491 g002b 550
Figure 2. UV of compounds 1–4, BSA and the BSA-compound complexes. Conditions: c (compound) = 12 × 10−6 mol∙L−1; c (BSA) = 1.04 × 10−6 mol∙L−1.
Figure 2. UV of compounds 1–4, BSA and the BSA-compound complexes. Conditions: c (compound) = 12 × 10−6 mol∙L−1; c (BSA) = 1.04 × 10−6 mol∙L−1.
Molecules 20 16491 g002aMolecules 20 16491 g002b
Molecules 20 16491 g003a 550Molecules 20 16491 g003b 550
Figure 3. UV absorption spectra of compounds 1–4 with BSA. Numbers 1–13 indicated the concentrations of compounds 1–4: 0.0, 0.4 × 10−6, 0.8 × 10−6, 1.2 × 10−6, 2.4 × 10−6, 3.6 × 10−6, 4.8 × 10−6, 6.0 × 10−6, 7.2 × 10−6, 8.4 × 10−6, 9.6 × 10−6, 10.8 × 10−6 and 12 × 10−6 mol∙L−1, respectively. BSA concentration applied was 1.04 × 10−6 mol∙L−1.
Figure 3. UV absorption spectra of compounds 1–4 with BSA. Numbers 1–13 indicated the concentrations of compounds 1–4: 0.0, 0.4 × 10−6, 0.8 × 10−6, 1.2 × 10−6, 2.4 × 10−6, 3.6 × 10−6, 4.8 × 10−6, 6.0 × 10−6, 7.2 × 10−6, 8.4 × 10−6, 9.6 × 10−6, 10.8 × 10−6 and 12 × 10−6 mol∙L−1, respectively. BSA concentration applied was 1.04 × 10−6 mol∙L−1.
Molecules 20 16491 g003aMolecules 20 16491 g003b

2.2. Fluorescence Spectroscopy

2.2.1. Fluorescence Quenching

To further investigate the BSA binding properties of naphthalimide-polyamine conjugates, FL spectrometry was applied because the inherent fluorescence of BSA allowed us to examine the compounds’ interaction with BSA. As shown Figure 4 and Figure 5, compounds 1, 3 and 4 have no emission from 290 to 500 nm while compound 2 had no emission from 290 to 365 nm, which implied compounds 1–4 had little effect on the fluorescence analysis. As also shown in Figure 4, the fluorescence intensities of BSA at 350 nm with an excitation wavelength of 280 nm exhibited a remarkable downward trend as the concentrations of compounds 2–4 increased. Thus indicated that the possible formation of relevant complexes between compounds 2–4 and BSA could influence the secondary structure of the protein that would in turn result in changes in the microenvironment around the tyrosine (Tyr) and tryptophan (Try) residues of BSA [22]. Surprisingly, the fluorescence quenching of BSA by compound 1 was somewhat irregular because of the occurrence of rebounds as the concentrations of compound 1 increased.
Molecules 20 16491 g004a 550Molecules 20 16491 g004b 550
Figure 4. Fluorescence spectroscopy of compounds 1–4 and BSA. Numbers 1–13 indicated concentrations of compounds 1–4: 0.0, 0.4 ×10−6, 0.8 × 10−6, 1.2 × 10−6, 2.4 × 10−6, 3.6 × 10−6, 4.8 × 10−6, 6.0 × 10−6, 7.2 × 10−6, 8.4 × 10−6, 9.6 × 10−6, 10.8 × 10−6 and 12 × 10−6 mol∙L−1, respectively. BSA concentration applied was 1.04 × 10−6 mol∙L−1. Scan condition: Ex = 280 nm, Em = 290–550 nm; slits of both Ex and Em of compounds 1–3 were 5 nm while those of compound 4 were 5 nm and 10 nm, respectively.
Figure 4. Fluorescence spectroscopy of compounds 1–4 and BSA. Numbers 1–13 indicated concentrations of compounds 1–4: 0.0, 0.4 ×10−6, 0.8 × 10−6, 1.2 × 10−6, 2.4 × 10−6, 3.6 × 10−6, 4.8 × 10−6, 6.0 × 10−6, 7.2 × 10−6, 8.4 × 10−6, 9.6 × 10−6, 10.8 × 10−6 and 12 × 10−6 mol∙L−1, respectively. BSA concentration applied was 1.04 × 10−6 mol∙L−1. Scan condition: Ex = 280 nm, Em = 290–550 nm; slits of both Ex and Em of compounds 1–3 were 5 nm while those of compound 4 were 5 nm and 10 nm, respectively.
Molecules 20 16491 g004aMolecules 20 16491 g004b
Molecules 20 16491 g005a 550Molecules 20 16491 g005b 550
Figure 5. Fuorescence of compounds 1–4, BSA and BSA + compounds 1–4. c (compound) = 12 × 10−6 mol∙L−1; c (BSA) = 1.04 × 10−6 mol∙L−1.
Figure 5. Fuorescence of compounds 1–4, BSA and BSA + compounds 1–4. c (compound) = 12 × 10−6 mol∙L−1; c (BSA) = 1.04 × 10−6 mol∙L−1.
Molecules 20 16491 g005aMolecules 20 16491 g005b
The fluorescence quenching ratio (F/F0) of BSA by compounds 1–4 and MINS at room temperatures was then obtained, in which F0 and F are the fluorescence intensities in the absence and presence of quenchers, respectively. In Figure 6, fluorescence quenching capability of compounds 1–4 and MINS [20] is depicted in the following order of 4 > 3 > 2 and MINS > 1. Compared to the parent compound MINS, the electron-withdrawn group (-NO2) facilitated the fluorescence quenching process, while the presence of electron-donor amino group displayed less impact on the corresponding quenching process.
Molecules 20 16491 g006 550
Figure 6. Fluorescence quenching ratio (F/F0) of BSA by compounds 1–4 and MINS at room temperatures.
Figure 6. Fluorescence quenching ratio (F/F0) of BSA by compounds 1–4 and MINS at room temperatures.
Molecules 20 16491 g006

2.2.2. Fluorescence Quenching Mechanism

Fluorescence quenching can occur by different mechanisms, which are usually classified as either dynamic or static quenching. Dynamic quenching results from the diffusive encounter between the quencher and fluorophore during the lifetime of an excited state, causing the bimolecular quenching constants to increase in value at higher temperatures. Static quenching, however, results from the formation of a ground state complex between the fluorophore and quencher. This concept thus explains the decrease in stabilities and static quenching constants as temperature elevates [23]. In order to draw clarity from the quenching mechanism of the interaction between naphthalimide-polyamine conjugates and BSA, fluorescence quenching tests as described by the Stern-Volmer equation were also carried out at 298, 303 and 310 K, respectively [2,24].
The Stern-Volmer equation is the following:
F0/F = 1 + KSV × c = 1+ K × τ0 × c
in which F0 and F are the same as described above. KSV is the Stern-Volmer quenching constant, [c] is the concentration of compounds 1–4, Kq is the biomolecule quenching rate constant, and τ0 is the average lifetime of the molecule without any quencher in Kq = KSV/τ0, with the average fluorescence lifetime of the biopolymer around 6.0 × 10−9 s at 298 K, (Figure S1 and Table S1) [25,26]. The Stern-Volmer plots of F0/F vs. [c] at the three temperatures were shown in Figure 7, and the calculated KSV and Kq values are listed in Table 1.
The values of Kq (>1012 L∙mol−1) were much higher than the diffusion limit for the quenching rate constant (2.000 × 1010 L∙mol−1) at 298 K, indicating that the fluorescence quenching mechanism of BSA initiated by compounds 1–4 was static quenching in nature because the diffusion limit for the quenching rate constant Kq of dynamic quenching of various quenchers with the biopolymer is 2.000 × 1010 L∙mol−1 [22]. The values of quenching constant KSV of compounds 1–3, however, generally increased with increasing temperature, which revealed that the interaction mechanisms of BSA initiated by compounds 1–3 were not typically static types and they were accompanied by dynamic quenching [27]. It is reported that static quenching constant does not necessarily decrease with increasing temperature, and it sometimes increases or stays constant [28,29,30,31]. Thus, the fluorescence quenching mechanism of BSA triggered by compounds 1–3 was overall static. On the contrary, the values of quenching constant KSV of compound 4 decreased with the increasing temperature, indicating that the fluorescence quenching mechanism of BSA initiated by compound 4 was a typically static type. Moreover, the values of quenching constant KSV of compounds 1–4 and MINS decreased in the following manner: 4 > 3 > 2 > MINS > 1, implying that the substituent groups affected the fluorescence quenching process of BSA by compounds 1–4, compared to MINS with a naked aromatic ring [20]. Moreover, compound 1, which has the electron-donor amino group, displayed the least impact on the corresponding quenching process, so it has the smallest quenching constant KSV value at room temperature. It is well known that the fluorescence of BSA results from Trp and Tyr residues. The fluorescence of BSA came from both Trp and Tyr residues with an excitation wavelength of 280 nm, while only Trp residues were excited at a 295 nm wavelength [32,33]. Therefore, the fluorescence of BSA with or without compounds at 298, 303 and 310 K was also measured at the excitation wavelength of 295 nm (Figures S2–S5 and Table S2).
Molecules 20 16491 g007a 550Molecules 20 16491 g007b 550
Figure 7. Stern-Volmer linear plot of fluorescence quenching of BSA by compounds 1–4 at different temperatures.
Figure 7. Stern-Volmer linear plot of fluorescence quenching of BSA by compounds 1–4 at different temperatures.
Molecules 20 16491 g007aMolecules 20 16491 g007b
Table
Table 1. Quenching constant of the interaction between compounds 1–4 and BSA at different temperatures.
Table 1. Quenching constant of the interaction between compounds 1–4 and BSA at different temperatures.
CompoundT (K)Ksv (L∙mol−1)Kq (1012 L∙mol−1)r
1298
303
310		(1.720 ± 0.243) × 104
(2.250 ± 0.252) × 104
(2.090 ± 0.295) × 104		(2.895 ± 0.409) × 10120.9133
0.9424
0.9137
2298
303
310		(3.190 ± 0.179) × 104
(5.020 ± 0.304) × 104
(5.200 ± 0.364) × 104		(5.369 ± 0.301) × 10120.9846
0.9822
0.9763
3298
303
310		(5.700 ± 0.223) × 104
(5.500 ± 0.318) × 104
(6.220 ± 0.304) × 104		(9.594 ± 0.375) × 10120.9924
0.9837
0.9883
4298
303
310		(4.745 ± 0.354) × 105
(4.159 ± 0.302) × 105
(3.864 ± 0.293) × 105		(7.987 ± 0.596) × 10130.9735
0.9747
0.9724
A comparison of the BSA fluorescence quenching excited at 280 and 295 nm allows us to evaluate the role of the Trp and Tyr groups in the complex. Indeed, an obviously decreased BSA fluorescence intensity was obtained using 295 nm as the excitation wavelength (Figure S5). In addition, the fluorescence quenching of BSA by compounds 2–4 when excited at 280 nm was more significant than at 295 nm. The KSV variation trend of compounds 2–4 excited at 295 nm was consistent with those at 280 nm. However, the distinctive behavior of compound 1 with a higher KSV value at 295 nm than at 280 nm, might originate from its unusual existence in BSA, as illustrated in subsequent molecular docking experiments. Finally, both the Kq values (>1012 L∙mol−1) at 280 and 295 nm corroborated that the fluorescence quenching mechanism of BSA initiated by compounds 1–4 was a static type.

2.2.3. Interaction Mode between Compounds 1–4 and BSA

For a static quenching process, when small molecules bind independently to a set of equivalent sites in a macromolecule, the binding constant (Kb) for a polyamine conjugate-BSA system can be determined by the following equation [34,35]:
Log [1/c] = log [F/(F0 − F)] + log Kb
in which Kb denotes the binding constant for the interaction between naphthalimide–BSA. F0, F, and [c] have the same definitions as described in Equation (1). The values of Kb were measured from the intercept and slope by plotting log [1/c] against log [F/(F0 − F)] (intercept = log Kb) (Figure 8), with the corresponding values of Kb presented in Table 2. The changes in trend of Kb with increasing temperatures were in accordance with KSV’s dependence on temperature as mentioned above, implying that the binding between naphthalimide and BSA was moderate, and a reversible naphthalimide-BSA complex might have been formed [36]. Experimental data showed that the values of binding constant Kb decreased in a manner similar to that of BSA at room temperature: 4 > 3 > 2 > MINS > 1, providing further evidence to the effect of substituent groups appending on naphthalimide (Table 2).
Molecules 20 16491 g008a 550Molecules 20 16491 g008b 550
Figure 8. Linear plot of log [1/ccomp.] vs. log [F/(F0 − F)] of the interaction between compounds 1–4 and BSA at different temperatures.
Figure 8. Linear plot of log [1/ccomp.] vs. log [F/(F0 − F)] of the interaction between compounds 1–4 and BSA at different temperatures.
Molecules 20 16491 g008aMolecules 20 16491 g008b
Table
Table 2. Binding constants and thermodynamic parameters of the interaction between compounds 1–4 and BSA at different temperatures.
Table 2. Binding constants and thermodynamic parameters of the interaction between compounds 1–4 and BSA at different temperatures.
CompoundT (K)Kb (L∙mol−1)∆G° (L∙mol−1)∆H° (kJ∙mol−1)∆S° (kJ∙mol−1)r
12981.438 × 104 ± 1.923−23.71852.0760.25430.8464
3036.879 × 104 ± 1.217−28.06052.0760.25430.8093
3103.244 × 104 ± 1.361−26.77152.0760.25430.9137
22982.541 × 104 ± 1.246−25.91391.6970.9320.9652
3034.680 × 104 ± 1.134−27.09091.6970.9320.9813
3106.823 × 104 ± 1.208−28.68791.6970.9320.9435
32985.040 × 104 ± 1.146−26.82714.9150.1400.9769
3035.567 × 104 ± 1.101−27.52714.9150.1400.9873
3106.281 × 104 ± 1.115−28.47414.9150.1400.9820
42982.341 × 105 ± 1.030−30.361−12.2210.1430.9961
3032.158 × 105 ± 1.022−30.940−12.2210.1430.9980
3101.847 × 105 ± 1.056−31.254−12.2210.1430.9884
The interactive forces between a small organic molecule and biomacromolecules may include hydrophobic forces, hydrogen bonds, van der Waals forces, and electrostatic interactions. It is assumed that the interaction enthalpy change (∆H°) varies significantly within the limited temperature range (entropy change, ∆S°) studied. Free energy change (∆G°) is calculated from van’t Hoff equation:
ln(K2/K1) = (1/T1 − 1/T2) ∆H°/R
∆G° = − RT lnK = ∆H° − T∆S°
In Equations (3) and (4), K is the binding constant at the corresponding temperature and R is the gas constant. Enthalpy change (∆H°) and entropy change (∆S°) are calculated from Equations (3) and (4), with the corresponding results listed in Table 2.
Ross et al. described the sign and magnitude of thermodynamic parameters associated with the various kinds of interaction, which might take place in protein-associated processes, as characterized below [37]: (a) positive ΔH and ΔS values are frequently taken as evidence for typical hydrophobic interactions; (b) negative ΔH and ΔS values arise from van der Waals forces and hydrogen bond formation; (c) positive ΔS and negative ΔH values are characterized as specific electrostatic interactions between ionic species in aqueous solution. In Table 2, the positive ∆H° and ∆S° values of compounds 1–3 indicated that hydrophobic interactions played a dominant role in the interactions between naphthalimides and BSA [37]. However, the negative ∆H° and positive ∆S° values of compound 4 showed that the electrostatic interaction played a dominant part in the interactions between polyamine conjugate 4 and BSA, which has two strong electron-withdrawing nitro-group and displayed the strongest impact on the corresponding binding process [37]. These results confirmed that substituent groups affected the interactive mode between naphthalimides and BSA.
The binding constant (Kb) and thermodynamic parameters of the interaction between compounds 1–4 and BSA were also assayed at an excited wavelength of 295 nm (Figure S4 and Table S3). The results showed the mode of interaction of BSA with compounds 1–4 was consistent with that at 280 nm. Surprisingly, the Kb values at 295 nm were distorted, making it difficult to see a pattern with related substituents on aromatic rings, compared to those at 280 nm.

2.2.4. Synchronous Fluorescence Spectroscopy

The synchronous fluorescence spectroscopy of BSA can provide characteristic information of tyrosine or tryptophan residues when wavelength interval (∆λ) between excitation wave length and emission wavelength is at 15 or 60 nm [38].
When compounds 1–3 were added to the BSA solution, fluorescence emission intensities of tyrosine residues increased or were quenched irregularly, and the corresponding wavelengths had no obvious shift (Figure 9A1–4). The fluorescence emission of tyrosine residues, however, was remarkably quenched as the concentration of compound 4 increased. In contrast, the addition of compounds 1–3 remarkably increased the fluorescence emission intensities of tryptophan residues with the irregular quenching caused by compound 4 (Figure 9B1–4). Compounds 1 and 3 resulted in a respective red shift of 16 and 6 nm, while compound 2 and 4 had no impact on the wavelength, which indicated that the hydrophobicity around the tryptophan residues was not increased [39].
Molecules 20 16491 g009a 550Molecules 20 16491 g009b 550Molecules 20 16491 g009c 550
Figure 9. Synchronous fluorescence spectra of compounds-BSA system. (A: Δλ = 15 nm, B: Δλ = 60 nm). The concentrations of BSA and compounds were the same as those in Figure 4.
Figure 9. Synchronous fluorescence spectra of compounds-BSA system. (A: Δλ = 15 nm, B: Δλ = 60 nm). The concentrations of BSA and compounds were the same as those in Figure 4.
Molecules 20 16491 g009aMolecules 20 16491 g009bMolecules 20 16491 g009c
These results suggested that compounds 1–4 were not easily localized in the hydrophobic cavity to bind with tyrosine and tryptophan residues. Thus these compounds had only a slight influence on the conformation of tyrosine residues in the subdomain of BSA. The formed compounds 1–4-BSA complexes lowered the hydrophobicity of tryptophan residues and in turn caused the structures to be less compact.

2.2.5. Three-Dimensional Fluorescence Spectroscopy Analysis

Three-dimensional fluorescence spectra of BSA in the absence and presence of compounds 1–4 were investigated. Figure 10A1–A4 depict the three-dimensional fluorescence spectra of BSA in the absence of compounds 1–4. Four peaks were found: peak a, peak b, peak 1 and peak 2, respectively. Peak a is the Rayleigh scattering peak (λex = λem), and peak b is the second-order scattering peak (2λex = λem) [40,41]. Peak 1 (λex = 280 nm, λem is about 350 nm), the primary fluorescence peak, represents the spectral characters of tyrosine and tryptophan residues [42,43,44]. Peak 2 (λex = 230 nm, λem is around 350 nm) accounts for the fluorescence may be from excitation of indole into S2 and subsequent emission from S1, undergoing intersystem crossing in BSA.
Molecules 20 16491 g010a 550Molecules 20 16491 g010b 550
Figure 10. Three-dimensional fluorescence spectra of BSA in the absence (A) and presence (B) of compounds 1–4. Conditions: c (BSA) = 1.04 × 10−6 mol∙L−1, c (compounds 1–4) = 12.0 × 10−6 mol∙L–1.
Figure 10. Three-dimensional fluorescence spectra of BSA in the absence (A) and presence (B) of compounds 1–4. Conditions: c (BSA) = 1.04 × 10−6 mol∙L−1, c (compounds 1–4) = 12.0 × 10−6 mol∙L–1.
Molecules 20 16491 g010aMolecules 20 16491 g010b
As shown in Figure 10B1–4, the presence of compounds 1–4 reduced the fluorescence intensity of peak 1 by 15.73%, 24.50%, 44.11% and 81.55%, respectively, implying the altered microenvironments of tyrosine and tryptophan residues [45]. The fluorescence intensity of peak 2 was also reduced by 25.13%, 40.01%, 37.32% and 55.76%, respectively, indicating that peptide strand structures of BSA were changed as well. These results supported that the interaction between compounds 1–4 and BSA triggered slightly microenvironmental and conformational alterations in BSA [46,47]. Besides, the reduced fluorescence intensity of peak 1 with the order of 4 > 3 > 2 > MINS > 1 at room temperature provided further evidence of the effect of substituent groups.

2.3. CD Measurement

Circular dichroism (CD) is one of the most valuable methods for examining conformational alterations in protein upon interaction with exogenous substances [48,49,50]. Thus, in order to obtain an insight into the structure of BSA complex, CD spectral study was carried out to observe the conformational change of BSA in the presence of compounds 1–4. The CD spectral study was carried out in PBS (pH = 7.4) buffer solution (Figure 11).
Molecules 20 16491 g011a 550Molecules 20 16491 g011b 550
Figure 11. CD spectra of BSA in the presence of the compounds. Conditions: c (BSA): 40.0 × 10–6 mol∙L–1; c (conpounds): 0, 120.0 × 10–6 mol∙L–1.
Figure 11. CD spectra of BSA in the presence of the compounds. Conditions: c (BSA): 40.0 × 10–6 mol∙L–1; c (conpounds): 0, 120.0 × 10–6 mol∙L–1.
Molecules 20 16491 g011aMolecules 20 16491 g011b
The CD spectra of free BSA displayed two negative bands at 209 and 220 nm, characteristics of the α-helix structure [51,52]. The CD spectra of BSA in presence and absence of compounds 1–4 were similar in shape, indicating that the structure of BSA was predominantly α-helix. In addition, the CD signal of BSA insignificantly decreased without any noteworthy wavelength shift in the presence of compounds 1–4 at the molar ratio of BSA to compounds 1:3.
From these results, it could be inferred that compounds 1–4 caused weak conformational changes in BSA without losing the original helical stability. In addition, protein conformational analysis based on CD data reported that the free BSA had a high α-helical content of 65.5%, antiparallel of 3.4%, parallel of 3.4%, turn of 12.4%, and random coil of 16.1% (Table 3). Upon addition of compounds 1–4, alterations of BSA conformation were not obvious as their respective values are within the typical margin of error, which implied polyamine conjugates caused little protein unfolding in the secondary structure of BSA and meant that compounds 1–4 could maintain the stability of the protein conformation [13]. These results were further supported by subsequent thermal stability and molecular docking experiments.
Table
Table 3. Secondary structure of compounds 1–4-BSA complex (CD Spectra) at pH 7.4 as calculated by CCDN software.
Table 3. Secondary structure of compounds 1–4-BSA complex (CD Spectra) at pH 7.4 as calculated by CCDN software.
Compounds 1–4 Concentration (μM)α-HelixAntiparallelParallelβ-TurnRandom CoilTotal Sum
Free BSA65.3%3.4%3.4%12.4%16.1%100.5%
compound 1-BSA67.8%3.1%3.1%12.1%15.0%101.1%
compound 2-BSA66.8%3.2%3.2%12.2%15.4%100.9%
compound 3-BSA61.0%3.8%3.9%13.0%17.9%99.6%
compound 4-BSA61.7%3.7%3.8%12.9%17.6%99.7%
Based on the facts mentioned above, we investigated the thermal stability of the protein as a consequence of binding. Thermal stability curves for compounds-BSA complex and BSA were plotted from 20 °C to 95 °C, as shown in Figure 12. The figure showed no obvious increase in melting temperature (Tm) between BSA alone and the compounds-BSA complex. The slight change in the melting temperature (Tm) of BSA implied that the presence of compounds 1–4 did not enhance the thermal stability of BSA and the binding of compounds with BSA resulted in weak structural alterations [51,53].
Molecules 20 16491 g012a 550Molecules 20 16491 g012b 550
Figure 12. Thermal denaturation of 40 × 10−6 mol∙L–1 BSA in the absence and presence of 120 × 10−6 mol∙L–1 compounds at pH = 7.4.
Figure 12. Thermal denaturation of 40 × 10−6 mol∙L–1 BSA in the absence and presence of 120 × 10−6 mol∙L–1 compounds at pH = 7.4.
Molecules 20 16491 g012aMolecules 20 16491 g012b

2.4. Docking Analysis

The 2-dimensional (2D) and corresponding 3-dimensional (3D) diagrams of the best binding mode of each system were plotted. Results showed that the DSI binding site, with regards to compounds 1–3, that the –COO− of Glu152 was keen on forming ion pairs with the –NH3+ group (–COO–∙∙∙–NH3+) from the compounds, thus forming a strong electrostatic interaction between the two groups. Additionally, in each of the compounds 2 and 3, the guanidinium group-π interaction was found between Arg194 of BSA protein and the compounds’ respective conjugate rings (Figure 13 and Table 4), an interaction that was also important in other proteins [54]. Moreover, the π-π interaction between the aromatic ring of Trp213 from BSA and the molecule’s conjugate ring also contributed greatly to the binding of BSA and compounds 2 and 3, respectively. For compound 4, two distinct hydrogen bonds were found between the carbonyl groups of the ligand and the -NH2 groups of Arg217 and Arg256; moreover, the C-H-π interaction was also identified between Ala290 and its conjugate ring. Corresponding binding free energy was abided in the following order: |∆G (compound 4)| > |∆G (compound 1)| > |∆G (compound 3)| > |∆G (compound 2)|, which might help explain the unique property of compound 1 observed at 295 nm.
Molecules 20 16491 g013 550
Figure 13. Docking experiment results showing the 2D diagrams of the binding modes of the complex DSI-compounds 1–4. Polar and non-polar residues were represented in red and green circles, respectively. H-bond acceptors or donors were shown in green-dotted arrows. Electrostatic interactions from ion pairs were presented in red-dotted lines. π-π and π-H interactions were represented in green-dotted lines.
Figure 13. Docking experiment results showing the 2D diagrams of the binding modes of the complex DSI-compounds 1–4. Polar and non-polar residues were represented in red and green circles, respectively. H-bond acceptors or donors were shown in green-dotted arrows. Electrostatic interactions from ion pairs were presented in red-dotted lines. π-π and π-H interactions were represented in green-dotted lines.
Molecules 20 16491 g013
At the DSII binding site, there was a π-CH3 hyperconjugation effect between the –CH3 group of Leu452 and the conjugate ring of each of the compounds 1–3. In addition, a similar interaction brought by Ile387 and Leu386 could be seen in compound 3. As for DSII-compound 4 complex, a strong electrostatic interaction was formed between the –COO– group of Glu382 and the –NH3+ group of the ligand. At the sites where the affinity energy was only slightly strengthened by electrostatic interaction, polar residues Arg484, Glu449, Thr448, Ser488, Tyr410 and Asn390 would form a cavity to localize the ligand. The corresponding binding free energies could be ordered in the following manner: |∆G (compound 4)| > |∆G (compound 3)| > |∆G (compound 2)| > |∆G (compound 1)|, which is consistent with experimental data at 298 K when an excitation wavelength 280 nm was used (Figure 14 and Table 4). It was worth noting that the ligands (except compound 1) were more likely to stay at the DSII than at DSI site. In other words, the binding sites of compounds 2–4 in BSA were the DSII ones, but compound 1 had not much selectivity to reside in the DSII or DSI site. What might account for this phenomenon was the exposed tail chain of the ligand to the outside of the protein at the DSII site, causing the polar solvent to reinforce the binding free energy (Figure 13). Interestingly, Tyr (other than Trp) residues in the favorable DSII cavity existed around the ligand. Indeed, the spectral data excited at 280 nm matched much better with the molecular docking results, implying the diverse role of Tyr and Trp residues in the detection of BSA-compounds interaction.
Molecules 20 16491 g014 550
Figure 14. Docking experiment results showing the 2D diagrams of the binding modes of the complex DSII-compounds 1–4. Polar and nonpolar residues were represented in the red and green circles, respectively. H-bond acceptors or donors were shown in green-dotted arrows. Electrostatic interactions from ion pairs were presented in red-dotted lines. π-π and π-H interactions were represented in green-dotted lines.
Figure 14. Docking experiment results showing the 2D diagrams of the binding modes of the complex DSII-compounds 1–4. Polar and nonpolar residues were represented in the red and green circles, respectively. H-bond acceptors or donors were shown in green-dotted arrows. Electrostatic interactions from ion pairs were presented in red-dotted lines. π-π and π-H interactions were represented in green-dotted lines.
Molecules 20 16491 g014
Table
Table 4. Results for the affinity ∆G scoring of molecular docking for BSA and compounds 1–4 (DSII refer to the main binding regions within domains II and III, named Sudlow’s sites).
Table 4. Results for the affinity ∆G scoring of molecular docking for BSA and compounds 1–4 (DSII refer to the main binding regions within domains II and III, named Sudlow’s sites).
SystemAffinity ∆G ScoringSystemAffinity ∆G Scoring
DSI–Compound 1–6.18DSII–Compound 1–6.28
DSI–Compound 2–5.12DSII–Compound 2–6.45
DSI–Compound 3–5.39DSII–Compound 3–7.41
DSI–Compound 4–7.45DSII–Compound 4–8.49

3. Experimental Section

3.1. Apparatus

UV-Vis absorption spectra were measured on a Unicam UV 500 spectrophotometer (Beijing, China) through a 1.0 cm cell. Fluorescence measurements were obtained from a Cary Eclipse spectrofluorimeter (Shanghai, China). The fluorescence lifetime of BSA was determined by a FLS980E-S1S1-tm Fluorescence Lifetime Spectrometer (Edinburgh, UK). Circular dichroism spectrum measurements were recorded from a Modle 420 SF (Lake Wood, NJ, USA) automatic recording spectrophotometer through a 1 mm quartz cell.

3.2. Materials

Naphthalimide-polyamine conjugates 1–4 were prepared previously [18]. The solutions were either prepared with Tris–HCl buffer solution (2.00 × 10–5 mol∙L–1 for UV and FL) or with phosphate buffer saline (PBS, pH = 7.4) buffer solution (2.00 × 10–4 mol∙L–1 for CD), and stored at 4 °C. BSA (Sino-American Biotechnology Company, Beijing, China) was used without further purification. And its stock solution, was either prepared by dissolving an appropriate amount of BSA in Tris-HCl (pH = 7.4) buffer solution (2.60 × 10–5 mol∙L–1 for UV and FL) or mixed with PBS (pH = 7.4) buffer solution (2.00 × 10–4 mol∙L–1 for CD), and stored at 4 °C.

3.3. Procedures

3.3.1. UV-Vis Measurements

A solution of BSA (0.2 mL, 2.60 × 10−5 mol∙L−1) in Tris-HCl (pH = 7.4) was mixed with 0.0, 0.10, 0.20, 0.30, 0.60, 0.90, 1.20, 1.50, 1.80, 2.10, 2.40, 2.70 and 3.00 mL of each compounds 1–4 (2.0 × 10–5 mol∙L−1), respectively. The mixture was also diluted to 5 mL with Tris-HCl (pH = 7.4). Thus, the final concentrations of samples were 0.0, 0.4, 0.8, 1.2., 2.4, 3.6, 4.8, 6.0, 7.2, 8.4, 9.6, 10.8 and 12.0 × 10–6 mol∙L−1, respectively. One sample that contained only BSA (1.04 × 10–6 mol∙L−1) served as control, while others contained different concentrations of compounds 1–4 but had the same concentration of BSA. All of the solutions were shaken for 30 min at room temperature.

3.3.2. Fluorescence Measurement

Interaction of Compounds 1–4 with BSA

The procedure for the preparation of samples was the same as that of UV-Vis samples. Fluorescence wavelengths and intensity areas of samples were measured at 298, 303 and 310 K in the wavelength range of 290–550 nm or 305–580 nm, with the exciting wavelength at 280 nm or 295 nm and the λem is about 350 nm.

Synchronous and Three-Dimensional Fluorescence Spectroscopy

Synchronous fluorescence spectroscopy of compounds 1, 3 and 4 was obtained with wavelength ranging from 230 to 320 nm (∆λ = 15 nm) and from 290 to 480 nm (∆λ = 60 nm) with the emission slit width of 10 nm. As for compound 2, the emission slit width was 10 nm for the measurement from 230 to 320 nm, and 5 nm for the measurement from 290 to 480 nm. Three-dimensional fluorescence spectroscopy was conducted under the following conditions: the emission wavelength was recorded from 240 to 550 nm, and the initial excitation wavelength was set at 230 nm with increments of 10 nm.

3.3.3. Fluorescence Lifetime Measurement

For lifetime measurements at the excitation wavelength of 295 nm, a laser, pulse width 0.871 ns, was used to excite the BSA (1.04 × 10–6 mol∙L–1). The fluorescence decays were deconvoluted and fitted using standard software to obtain lifetimes. The averaged fluorescence lifetime was calculated according to [55].

3.3.4. CD Measurement

A solution of BSA (2 mL, 2.00 × 10−4mol∙L−1) in PBS (pH = 7.4) was mixed with 0 and 3.00 mL of compounds 1–4 (2.00 × 10−4 mol∙L–1), respectively. The mixture was diluted to 5 mL with PBS (pH = 7.4). Thus, samples were prepared in concentrations of 0.0 and 120.0 × 10−6 mol∙L−1, respectively. One sample that contained only BSA (40 × 10–6 mol∙L−1) served as control, while others contained different concentrations of compounds 1–4 but had the same concentration of BSA. All of above solutions were shaken for 30 min at room temperature. Temperature scans were carried out between 20 °C and 95 °C, with a scan rate of 1 °C/s and a path length cuvette of 1 mm. The wavelength used was 222 nm.

3.3.5. Molecular Modeling Study

To fully understand the mechanism of the interaction between compounds 1–4 and BSA (PDB ID: 4JK4), molecular modeling study in silico was performed by using the MOE 2013 Program [56,57,58]. Protonation states of ionizable residues were determined at pH = 7.4. Ligand conformation was identified with minimization. Herein, both the protein and compounds were treated with Amber99SB [59,60,61] with the Merck molecular force field set to 94 s parameters [62]. Two enzymatic drug sites (DSI and DSII) served as docking sites, and eight systems were generated, with each system analyzed in great detail. Affinity ∆G and London ∆G scoring were used to estimate the binding mode. 500 random conformations were produced, with the 10 most optimal used for analysis.

4. Conclusions

The interaction between compounds 1–4 and BSA was studied by spectroscopic methods and molecular docking experiments. The presence of substituent groups on the naphthalimide backbone resulted in a series of changes in the spectral characteristics of the compounds-BSA complexes, with the exceptional behavior of the amino group on the aromatic ring of compound 1 being particularly notable. From the experimental results, it could be affirmed that compounds 1–4 were able to effectively combine with BSA and the quenching mechanism was static. Furthermore, the fluorescence quenching data measured at different temperatures (298, 303 and 310 K) suggested that the type of force acting in the compounds 1–3-BSA interaction was mainly hydrophobic in nature. However, synchronous and 3-D fluorescence spectral data provided some evidence for the presence of these hydrophobic interactions between compounds 1–4 and BSA. Moreover, compounds 1–4 had only weak influences on conformational changes of BSA throughout the BSA binding process. Molecular mechanism calculations were carried out and the calculated results suggested that enzymatic drug site II had little priority over enzymatic drug site I, as the calculated binding-affinity scoring of DSI-compound 1 and DSII-compound 1 was almost the same in value. This might support the abnormal spectral characteristic of compound 1-BSA complex. However, the DSII in BSA protein was more beneficial than its DSI counterpart in terms of binding with compounds 2–4 because the calculated binding affinity scorings of DSI-compounds 2–4 were significantly higher than those of DSII-compounds 2–4. Based on simulation results of DSII-compounds 1–4, the main force that governed the complex of compounds 1–3-BSA protein was hydrophobic interaction, as seen by π∙∙∙–CH3 hyper- conjugation between the conjugate ring of each of the compounds 1 and 2 and the –CH3 group of Leu452 from BSA, as well as between compound 3 and Leu452, Ile387 and Leu386 from BSA. The hydrophobic nature of interactions was confirmed by thermodynamic experimental results that showed positive ΔH and ΔS values. The strong electrostatic interactions formed from the charged interaction between the –NH3+ group of compound 4 and –COO– group of Glu382, and between the compound’s charged conjugate ring and the charged cavity constructed by the residues (Arg484, Glu449 et al.) of BSA protein were the main contributors to the binding of compound 4 and the BSA protein, findings supported by thermodynamic results that reported a positive ΔS (0.143 kJ∙mol−1) and negative ΔH (−12.221 kJ∙mol−1) values, according to Ross et al. [37].

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/20/09/16491/s1.

Acknowledgments

This work was supported by China Postdoctoral Science Foundation Funding (No. 20110490991), Henan Natural Science Foundation (No. 134200510009), Henan Programs for Science and Technology Development (No. 132102310026) and Natural Science Foundation of Education (No. 2011B3500001, 14A350004). We wish to thank DDDC of School of Pharmaceutical Sciences, Sun Yat-sen University for providing us with the MOE 2013 Program software for the virtual docking simulation work.

Author Contributions

Zhi-Yong Tian, Xue-Jun Xu and Chao-Jie Wang designed the research; all authors performed the experimental work; Zhi-Yong Tian, Xue-Jun Xu and Chao-Jie wrote the manuscript; all authors who are Zhi-Yong Tian, Li-Na Song, Yuan Zhao, Feng-Lei Zang, Zhong-Hua Zhao, Nan-Hao Chen, Xue-Jun Xu and Chao-Jie Wang discussed, edited and approved the final version.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Cui, F.L.; Fan, J.; Li, J.P.; Hu, Z.D. Interactions between 1-benzoyl-4-p-chlorophenyl thiosemicarbazide and serum albumin: Investigation by fluorescence spectroscopy. Bioorg. Med. Chem. 2004, 12, 151–157. [Google Scholar] [CrossRef] [PubMed]
  2. Sun, Y.; Wei, S.; Yin, C.; Liu, L.S.; Hu, C.M.; Zhao, Y.Y.; Ye, Y.X.; Hu, X.Y.; Fan, J. Synthesis and spectroscopic characterization of 4-butoxyethoxy-N-octadecyl-1,8-naphthalimide as a new fluorescent probe for the determination of proteins. Bioorg. Med. Chem. Lett. 2011, 21, 3798–3804. [Google Scholar] [CrossRef] [PubMed]
  3. Zhu, X.S.; Sun, J.; Hu, Y.Y. Determination of protein by hydroxypropyl-β-cyclodextrin sensitized fluorescence quenching method with erythrosine sodium as a fluorescence probe. Anal. Chim. Acta 2007, 596, 298–302. [Google Scholar] [CrossRef] [PubMed]
  4. Shrivastaw, K.P.; Singh, S.; Sharma, S.B. Quantitation of protein content by biuret method during production of yellow fever vaccine. Biologicals 1995, 23, 299–300. [Google Scholar] [CrossRef] [PubMed]
  5. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
  6. Wang, X.X.; Shen, H.X.; Hao, Y.M. Resonance light scattering of protein-amaranth system and its analytical application. Chin. J. Anal. Chem. 2000, 28, 1388–1390. [Google Scholar]
  7. Guo, C.Y.; Wu, X.; Yang, J.H.; Wang, F.; Jia, Z.; Ran, D.H.; Zheng, J.H. Determination of proteins using fluorescence enhancement of Tb3+-benzoyl-acetone-sodium dodecyl benzene sulfonate-protein system. J. Photochem. Photobiol. A 2006, 181, 50–51. [Google Scholar] [CrossRef]
  8. Flores, R. A rapidand reproducible for quantitative estimation Bromphenol Blue. Anal. Biochem. 1978, 88, 605–611. [Google Scholar] [CrossRef] [PubMed]
  9. Braña, M.F.; Ramos, A. Naphthalimides as anticancer agents: Synthesis and biological activity. Curr. Med. Chem. Anti-Cancer Agents 2001, 1, 237–255. [Google Scholar] [CrossRef] [PubMed]
  10. Braña, M.F.; Cacho, M.; Gradillas, A.; de Pascual-Teresa, B.; Ramos, A. Intercalators as anticancer drugs. Curr. Pharm. Des. 2001, 7, 1745–1780. [Google Scholar] [CrossRef] [PubMed]
  11. Beauchemin, R.; N’soukpoe-Kossi, C.N.; Thomas, T.; Thomas, T.J.; Carpentier, R.; Tajmir-Riahi, H.A. Polyamine analogues bind human serum albumin. Biomacromolecules 2007, 8, 3177–3183. [Google Scholar] [CrossRef] [PubMed]
  12. Ouameur, A.A.; Mangier, E.; Diamantoglou, S.; Rouillon, R.; Carpentier, R.; Tajmir-Riahi, H.A. Effects of organic and inorganic polyamine cations on the structure of human serum albumin. Biopolymers 2004, 73, 503–509. [Google Scholar] [CrossRef] [PubMed]
  13. Essemine, J.; Hasni, I.; Carpentier, R.; Thomas, T.J.; Tajmir-Riahi, H.A. Binding of biogenic and synthetic polyamines to β-lactoglobulin. Int. J. Biol. Macromol. 2011, 49, 201–209. [Google Scholar] [CrossRef] [PubMed]
  14. Dubeau, S.; Bourassa, P.; Thomas, T.J.; Tajmir-Riahi, H.A. Biogenic and synthetic polyamines bind bovine serum albumin. Biomacromolecules 2010, 11, 1507–1515. [Google Scholar] [CrossRef] [PubMed]
  15. Yang, L.H.; Zhao, J.; Zhu, Y.Q.; Tian, Z.Y.; Wang, C.J. Reactive oxygen species (ROS) accumulation induced by mononaphthalimide-spermidine leads to intrinsic and AIF-mediated apoptosis in HeLa cells. Oncol. Rep. 2011, 25, 1099–1107. [Google Scholar] [PubMed]
  16. Tian, Z.Y.; Su, L.P.; Xie, S.Q.; Zhao, J.; Wang, C.J. Synthesis, biological activitity and fluorescence spectroscopy of naphthalimide-polyamine conjugates. Chin. J. Org. Chem. 2013, 33, 1514–1521. [Google Scholar] [CrossRef]
  17. Tian, Z.Y.; Li, J.H.; Li, Q.; Zang, F.L.; Zhao, Z.H.; Wang, C.J. Study on the Synthesis, biological activity and spectroscopy of naphthalimide-diamine conjugates. Molecules 2014, 19, 7646–7668. [Google Scholar] [CrossRef] [PubMed]
  18. Tian, Z.Y.; Xie, S.Q.; Du, Y.W.; Ma, Y.F.; Zhao, J.; Gao, W.Y.; Wang, C.J. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents. Eur. J. Med. Chem. 2009, 44, 393–399. [Google Scholar] [CrossRef] [PubMed]
  19. Tian, Z.Y.; Zhao, Z.H.; Zang, F.L.; Wang, Y.Q.; Wang, C.J. Spectroscopic study on the interaction between naphthalimide-polyamine conjugates and DNA. J. Photochem. Photobiol. B 2014, 138, 202–210. [Google Scholar] [CrossRef] [PubMed]
  20. Tian, Z.Y.; Zang, F.L.; Luo, W.; Zhao, Z.H.; Wang, Y.Q.; Xu, X.J.; Wang, C.J. Spectroscopic study on the interaction between mononaphthalimide spermidine (MINS) and bovine serum albumin (BSA). J. Photochem. Photobiol. B 2015, 142, 103–109. [Google Scholar] [CrossRef] [PubMed]
  21. Sun, Y.; Liu, Z.; Liang, X.H.; Fan, J.; Han, Q. Study on photophysical and aggregation induced emission recognition of 1,8-naphthalimide probe for casein by spectroscopic method. Spectrochim. Acta A 2013, 108, 8–15. [Google Scholar] [CrossRef] [PubMed]
  22. Bhat, S.S.; Kumbhar, A.A.; Heptullah, H.; Khan, A.A.; Gobre, V.V.; Gejji, S.P.; Puranik, V.G. Synthesis, electronic structure, DNA and protein binding, DNA cleavage, and anticancer activity of fluorophore-labeled copper(II) complexes. Inorg. Chem. 2011, 50, 545–558. [Google Scholar] [CrossRef] [PubMed]
  23. Hu, Y.J.; Liu, Y.R.; Zhao, M.; Dong, J.X.; Qu, S.S. Spectroscopic studies on the interaction between methylene blue and bovine serum albumin. J. Photochem. Photobiol. A 2006, 179, 324–329. [Google Scholar] [CrossRef]
  24. Gelamo, E.L.; Silva, C.H.; Imasato, H.; Tabak, M. Interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants: Spectroscopy and modeling. Biochim. Biophys. Acta 2002, 1594, 84–89. [Google Scholar] [CrossRef]
  25. De, S.; Girigoswami, A.; Das, S. Fluorescence probing of albumin–surfactant interaction. J. Coll. Int. Sci. 2005, 285, 562–573. [Google Scholar] [CrossRef] [PubMed]
  26. Matei, I.; Ionescu, S.; Hillebrand, M. Interaction of fisetin with human serum albumin by fluorescence, circular dichroism spectroscopy and DFT calculations: Binding parameters and conformational changes. J. Lumin. 2011, 131, 1629–1635. [Google Scholar] [CrossRef]
  27. Hu, Y.J.; Liu, Y.; Zhang, L.X.; Zhao, R.M.; Qu, S.S. Study of interaction between colchicines and bovine serum albumin by fluorescence quenching method. J. Mol. Struct. 2005, 750, 174–178. [Google Scholar] [CrossRef]
  28. Zhang, J.; Chen, L.N.; Zeng, B.R.; Kang, Q.L.; Dai, L.Z. Study on the binding of chloroamphenicol with bovine serum albumin by fluorescence and UV-vis spectroscopy. Spectrochim. Acta A 2010, 77, 430–436. [Google Scholar] [CrossRef] [PubMed]
  29. Xue, J.J.; Chen, Q.Y. The interaction between ionic liquids modified magnetic nanoparticles and bovine serum albumin and the cytotoxicity to HepG-2 cells. Spectrochim. Acta A 2014, 120, 161–166. [Google Scholar] [CrossRef] [PubMed]
  30. Xu, H.; Liu, Q.W.; Wen, Y.Q. Spectroscopic studies on the interaction between nicotinamide and bovine serum albumin. Spectrochim. Acta A 2008, 71, 984–988. [Google Scholar] [CrossRef] [PubMed]
  31. Lin, H.; Lan, J.F.; Guan, M.; Sheng, F.L.; Zhang, H.X. Spectroscopic investigation of interaction between mangiferin and bovine serum albumin. Spectrochim. Acta A 2009, 73, 936–941. [Google Scholar] [CrossRef] [PubMed]
  32. Nanda, R.K.; Sarkar, N.; Banerjee, R. Probing the interaction of ellagic acid with human serum albumin: A fluorescence spectroscopic study. J. Photochem. Photobiol. A 2007, 192, 152–158. [Google Scholar] [CrossRef]
  33. Memarpoor-Yazdi, M.; Mahaki, H. Probing the interaction of human serum albumin with vitamin B2 (riboflavin) and L-Arginine (L-Arg) using multi-spectroscopic, molecular modeling and zeta potential techniques. J. Lumin. 2013, 136, 150–159. [Google Scholar] [CrossRef]
  34. Sirajuddin, M.; Ali, S.; Badshah, A. Drug-DNA interactions and their study by UV-Visible, fluorescence spectroscopies and cyclic voltametry. J. Photochem. Photobiol. B 2013, 124, 1–19. [Google Scholar] [CrossRef] [PubMed]
  35. Feng, Q.; Li, N.Q.; Jiang, Y.Y. Electrochemical studies of porphyrin interacting with DNA and determination of DNA. Anal. Chim. Acta 1997, 344, 97–104. [Google Scholar] [CrossRef]
  36. Hu, Y.J.; Liu, Y.; Xiao, X.H. Investigation of the interaction between Berberine and human serum albumin. Biomacromolecules 2009, 10, 517–521. [Google Scholar] [CrossRef] [PubMed]
  37. Ross, P.D.; Subramanian, S. Thermodynamics of protein association reactions: Forces contributing to stability. Biochemistry 1981, 20, 3096–3102. [Google Scholar] [CrossRef] [PubMed]
  38. Liu, Y.H.; Zhao, G.J.; Li, G.Y.; Han, K.L. Fluorescence quenching phenomena facilitated by excited-state hydrogen bond strengthening for fluorenone derivatives in alcohols. J. Photochem. Photobiol. A 2010, 209, 181–184. [Google Scholar] [CrossRef]
  39. Horne, D.S. Casein micelle structure and stability. In Milk Proteins-From Expression to Food; Thompson, A., Boland, M., Singh, H., Eds.; Academic Press: New York, NY, USA, 2008; pp. 133–162. [Google Scholar]
  40. Zhang, Y.Z.; Chen, X.X.; Dai, J.; Zhang, X.P.; Liu, Y.X.; Liu, Y. Spectroscopic studies on the interaction of lanthanum(III) 2-oxo-propionic acid salicyloyl hydrazone complex with bovine serum albumin. Luminescence 2008, 23, 150–156. [Google Scholar] [CrossRef] [PubMed]
  41. Zhang, Y.X.; Xiang, X.; Mei, P.; Dai, J.; Zhang, L.L.; Liu, Y. Spectroscopic studies on the interaction of congo red with bovine serum albumin. Spectrochim. Acta A 2009, 72, 907–914. [Google Scholar] [CrossRef] [PubMed]
  42. Zhang, N.L.; Wu, F.Y.; Liu, A.H. Study of the interaction between 2,5-di-[2-(4-hydroxy-phenyl)ethylene]-terephthalonitril and bovine serum albumin by fluorescence spectroscopy. Spectrochim. Acta A 2011, 79, 97–103. [Google Scholar] [CrossRef] [PubMed]
  43. Wang, Y.Q.; Tang, B.P.; Zhang, H.M.; Zhou, Q.H.; Zhang, G.C. Studies on the interaction between imidacloprid and human serum albumin: Spectroscopic approach. J. Photochem. Photobiol. B 2009, 94, 183–190. [Google Scholar] [CrossRef] [PubMed]
  44. Sandhya, B.; Hegde, A.H.; Kalanur, S.S.; Katrahalli, U.; Seetharamap, J. Interaction of triprolidine hydrochloride with serum albumins: Thermodynamic and binding characteristics, and influence of site probes. J. Pharm. Biomed. Anal. 2011, 54, 1180–1186. [Google Scholar] [CrossRef] [PubMed]
  45. Muller-Renaud, S.; Dupont, D.; Dulieu, P. Development of a biosensor immunoassay for the quantification of alphas1-casein in milk. J. Dairy. Res. 2005, 72, 57–64. [Google Scholar] [CrossRef] [PubMed]
  46. Zhou, X.M.; Yue, Y.Y.; Yang, Q.; Yan, N.; Chen, X.G. Complexes between C.I. Acid Orange 6 and human serum albumin, a multi-spectroscopic approach to investigate the binding behavior. J. Lumin. 2011, 131, 1222–1228. [Google Scholar] [CrossRef]
  47. Mahaki, H.; Memarpoor-Yazdi, M.; Chamani, J.; Saberi, M.R. Interaction between ropinirole hydrochloride and aspirin with human serum albumin as binary and ternary systems by multi-spectroscopic, molecular modeling and zeta potential. J. Lumin. 2013, 134, 758–771. [Google Scholar] [CrossRef]
  48. Li, M.; Liu, J.; Ran, X.; Fang, M.; Shi, J.; Qin, H.; Goh, J.M.; Song, J. Resurrecting abandoned proteins with pure water: CD and NMR studies of protein fragments solubilized in salt-free water. Biophys. J. 2006, 91, 4201–4209. [Google Scholar] [CrossRef] [PubMed]
  49. Chi, Z.; Liu, R. Phenotypic characterization of the binding of tetracycline to human serum albumin. Biomacromolecules 2011, 12, 203–209. [Google Scholar] [CrossRef] [PubMed]
  50. Fuchs, P.F.J.; Bonvin, A.M.J.J.; Bochicchio, B.; Pepe, A.; Alix, A.J.P.; Tamburro, A.M. Kinetics and thermodynamics of type VIII beta-turn formation: A CD, NMR, and microsecond explicit molecular dynamics study of the GDNP tetrapeptide. Biophys. J. 2006, 90, 2745–2759. [Google Scholar] [CrossRef] [PubMed]
  51. Ojha, H.; Mishra, K.; Hassan, M.I.; Chaudhury, N.K. Spectroscopic and isothermal titration calorimetry studies of binding interaction of ferulic acid with bovine serum albumin. Thermochim. Acta 2012, 548, 56–64. [Google Scholar] [CrossRef]
  52. Zhang, G.W.; Zhao, N.; Wang, L. Fluorescence spectrometric studies on the binding of puerarin to human serum albumin using warfarin, ibuprofen and digitoxin as site markers with the aid of chemometrics. J. Lumin. 2011, 131, 2716–2724. [Google Scholar] [CrossRef]
  53. Ojha, H.; Murari, B.M.; Anand, S.; Hassan, M.I.; Ahmad, F.; Chaudhury, N.K. Interaction of DNA minor groove binder Hoechst 33258 with bovine serum albumin. Chem. Pharm. Bull. 2009, 57, 481–486. [Google Scholar] [CrossRef] [PubMed]
  54. Brandl, M.; Weiss, M.S.; Jabs, A.; Sühnel, J.; Hilgenfeld, R. C-H⋯π-interactions in proteins. J. Mol. Biol. 2001, 307, 357–377. [Google Scholar] [CrossRef] [PubMed]
  55. Otosu, T.; Nishimoto, E.; Yamashita, S. Multiple conformational state of human serum albuminaround single tryptophan residue at various pH revealed by time-resolved fluorescence spectroscopy. J. Biochem. 2010, 147, 191–200. [Google Scholar] [CrossRef] [PubMed]
  56. Mittal, A.; Paliwal, S.; Sharma, M.; Singh, A.; Sharma, S.; Yadav, D. Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity. Bioorg. Med. Chem. Lett. 2014, 24, 3137–3141. [Google Scholar] [CrossRef] [PubMed]
  57. The PyMOL Molecular Graphics System; DeLano Scientific: San Carlos, CA, USA, 2002.
  58. Sekula, B.; Zielinski, K.; Bujacz, A. Crystallographic studies of the complexes of bovine and equine serum albumin with 3,5-diiodosalicylic acid. Int. J. Biol. Macromol. 2013, 60, 316–324. [Google Scholar] [CrossRef] [PubMed]
  59. Cornell, W.D.; Cieplak, P.; Bayly, C.I.; Gould, I.R.; Merz, K.M.; Ferguson, D.M.; Spellmeyer, D.C.; Fox, T.; Caldwell, J.W.; Kollman, P.A. A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J. Am. Chem. Soc. 1995, 117, 5179–5197. [Google Scholar] [CrossRef]
  60. Hornak, V.; Abel, R.; Okur, A.; Strockbine, B.; Roitberg, A. Simmerling, C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 2006, 65, 712–725. [Google Scholar] [CrossRef] [PubMed]
  61. Wang, J.M.; Cieplak, P.; Kollman, P.A. How Well Does a Restrained Electrostatic Potential (RESP) Model perform in calcluating conformational energies of organic and biological molecules? J. Comput. Chem. 2000, 21, 1049–1074. [Google Scholar] [CrossRef]
  62. Halgren, T.A. Merck molecular force field: I–V. J. Comput. Chem. 1996, 17, 490–641. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds are available from the authors.

Share and Cite

MDPI and ACS Style

Tian, Z.-Y.; Song, L.-N.; Zhao, Y.; Zang, F.-L.; Zhao, Z.-H.; Chen, N.-H.; Xu, X.-J.; Wang, C.-J. Spectroscopic Study on the Interaction between Naphthalimide-Polyamine Conjugates and Bovine Serum Albumin (BSA). Molecules 2015, 20, 16491-16523. https://doi.org/10.3390/molecules200916491

AMA Style

Tian Z-Y, Song L-N, Zhao Y, Zang F-L, Zhao Z-H, Chen N-H, Xu X-J, Wang C-J. Spectroscopic Study on the Interaction between Naphthalimide-Polyamine Conjugates and Bovine Serum Albumin (BSA). Molecules. 2015; 20(9):16491-16523. https://doi.org/10.3390/molecules200916491

Chicago/Turabian Style

Tian, Zhi-Yong, Li-Na Song, Yuan Zhao, Feng-Lei Zang, Zhong-Hua Zhao, Nan-Hao Chen, Xue-Jun Xu, and Chao-Jie Wang. 2015. "Spectroscopic Study on the Interaction between Naphthalimide-Polyamine Conjugates and Bovine Serum Albumin (BSA)" Molecules 20, no. 9: 16491-16523. https://doi.org/10.3390/molecules200916491

Article Metrics

Back to TopTop